Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice.
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru OS, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, Rodrigues KA, Silva M, Johnston RS, Naranjo CA, Tracey MK, Brady JR, Whittaker CA, Yun D, Brunette N, Wang JY, Walkey C, Fiala B, Kar S, Porto M, Lok M, Andersen H, Lewis MG, Love KR, Camp DL, Silverman JM, Kleanthous H, Joshi SB, Volkin DB, Dubois PM, Collin N, King NP, Barouch DH, Irvine DJ, Love JC. Dalvie NC, et al. Among authors: lebas c. Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):e2106845118. doi: 10.1073/pnas.2106845118. Proc Natl Acad Sci U S A. 2021. PMID: 34493582 Free PMC article.
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamsters.
Dalvie NC, Rodriguez-Aponte SA, Hartwell BL, Tostanoski LH, Biedermann AM, Crowell LE, Kaur K, Kumru O, Carter L, Yu J, Chang A, McMahan K, Courant T, Lebas C, Lemnios AA, Rodrigues KA, Silva M, Johnston RS, Naranjo CA, Tracey MK, Brady JR, Whittaker CA, Yun D, Kar S, Porto M, Lok M, Andersen H, Lewis MG, Love KR, Camp DL, Silverman JM, Kleanthous H, Joshi SB, Volkin DB, Dubois PM, Collin N, King NP, Barouch DH, Irvine DJ, Love JC. Dalvie NC, et al. Among authors: lebas c. bioRxiv [Preprint]. 2021 Mar 4:2021.03.03.433558. doi: 10.1101/2021.03.03.433558. bioRxiv. 2021. Update in: Proc Natl Acad Sci U S A. 2021 Sep 21;118(38):e2106845118. doi: 10.1073/pnas.2106845118 PMID: 33688647 Free PMC article. Updated. Preprint.
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
Ludwig J, Scally SW, Costa G, Hoffmann S, Murugan R, Lossin J, Prieto K, Obraztsova A, Lobeto N, Franke-Fayard B, Janse CJ, Lebas C, Collin N, Binter S, Kellam P, Levashina EA, Wardemann H, Julien JP. Ludwig J, et al. Among authors: lebas c. NPJ Vaccines. 2023 Apr 7;8(1):52. doi: 10.1038/s41541-023-00653-7. NPJ Vaccines. 2023. PMID: 37029167 Free PMC article.
Author Correction: Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
Ludwig J, Scally SW, Costa G, Hoffmann S, Murugan R, Lossin J, Prieto K, Obraztsova A, Lobeto N, Franke-Fayard B, Janse CJ, Lebas C, Collin N, Binter S, Kellam P, Levashina EA, Wardemann H, Julien JP. Ludwig J, et al. Among authors: lebas c. NPJ Vaccines. 2023 Jun 5;8(1):86. doi: 10.1038/s41541-023-00687-x. NPJ Vaccines. 2023. PMID: 37277334 Free PMC article. No abstract available.
Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
McMillan CLD, Cheung STM, Modhiran N, Barnes J, Amarilla AA, Bielefeldt-Ohmann H, Lee LYY, Guilfoyle K, van Amerongen G, Stittelaar K, Jakob V, Lebas C, Reading P, Short KR, Young PR, Watterson D, Chappell KJ. McMillan CLD, et al. Among authors: lebas c. NPJ Vaccines. 2021 Nov 8;6(1):135. doi: 10.1038/s41541-021-00395-4. NPJ Vaccines. 2021. PMID: 34750396 Free PMC article.
Author Correction: Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.
McMillan CLD, Cheung STM, Modhiran N, Barnes J, Amarilla AA, Bielefeldt-Ohmann H, Lee LYY, Guilfoyle K, van Amerongen G, Stittelaar K, Jakob V, Lebas C, Reading P, Short KR, Young PR, Watterson D, Chappell KJ. McMillan CLD, et al. Among authors: lebas c. NPJ Vaccines. 2022 Jan 5;7(1):3. doi: 10.1038/s41541-021-00428-y. NPJ Vaccines. 2022. PMID: 34987159 Free PMC article. No abstract available.
Real-life use of the PEXIVAS reduced-dose glucocorticoid regimen in granulomatosis with polyangiitis and microscopic polyangiitis.
Nagle S, Nguyen Y, Guerry MJ, Quemeneur T, Titeca-Beauport D, Crépin T, Mesbah R, Boudhabhay I, Pugnet G, Lebas C, Néel A, Karras A, Hachulla E, Woessner J, Pestre V, Borie R, Vinzio S, Gouin JB, Melboucy-Belkhir S, Outh R, Subran B, Gerfaud-Valentin M, Humbert S, Kerschen P, Uzunhan Y, Goulenok T, Beydon M, Costedoat-Chalumeau N, Puechal X, Terrier B. Nagle S, et al. Among authors: lebas c. Ann Rheum Dis. 2024 Nov 20:ard-2024-226339. doi: 10.1136/ard-2024-226339. Online ahead of print. Ann Rheum Dis. 2024. PMID: 39567200
The predictive performance of the ANCA renal risk score in patients over 65 years of age with renal ANCA-associated vasculitis.
de Berny Q, Diouf M, Mesbah R, Quemeneur T, Lebas C, Guerrot D, Hachulla E, Gibier JB, Cordonnier C, Francois A, Gueutin V, Choukroun G, Titeca-Beauport D. de Berny Q, et al. Among authors: lebas c. Clin Kidney J. 2024 Apr 29;17(8):sfae135. doi: 10.1093/ckj/sfae135. eCollection 2024 Aug. Clin Kidney J. 2024. PMID: 39421235 Free PMC article.
41 results